BioSpace News Archive

Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) (“Company”) announced today that the U.S. Food and Drug Administration (“FDA”) has completed the safety review of the Company’s Investigational New Drug (“IND”) application and has concluded that Adamis may proceed with the proposed clinical investigation of Tempol for the treatment of COVID-19.

TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced the appointment of four new members to the company’s board of directors including the appointment of former Pfizer CEO and Chairman Ian Read as the company’s new Chairman of the Board.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced an update on its broad spectrum anti-viral platform compounds with the potential to treat influenza, COVID-19, Ebola and other viral infections.

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, today announced the release of its annual financial results for the years ended December 31, 2020 and 2019.

MediXall Group, Inc., a healthcare technology company, announced that it has engaged ClearTrust, LLC as the Company’s new transfer agent and registrar for the Company’s stock effective immediately.

Premier Health of America Inc. (TSXV: PHA) (“Premier Health” or the “Corporation”), a leading Canadian Healthtech company, is pleased to announce that it has closed its previously announced bought deal prospectus offering of 7,130,000 common shares of the Corporation at a price of $1.05 per share (the “Offering Price”) for gross proceeds of $7,486,500 (the “Offering”)

EnPro Industries, Inc. (NYSE: NPO) will present at J.P. Morgan Global High Yield & Leveraged Finance Conference on Tuesday, March 2.

FUJIFILM Sonosite, Inc. , the world leader in point-of-care ultrasound solutions, announced today that Kaweah Delta Medical Center’s Emergency Department has gone live with Sonosite Synchronicity™, a comprehensive point-of-care ultrasound (POCUS) workflow solution.

Target RWE, a leading real-world evidence (RWE) solutions company for the pharmaceutical and biotech industries, announced newest data from its ongoing nonalcoholic steatohepatitis (NASH) observational study, published in Hepatology Communications (https://doi.org/10.1002/hep4.1689).

Piccolo Medical, Inc. announces that it has received FDA clearance of its SmartPICC ™ System. The SmartPICC™ System provides caregivers the ability to navigate peripherally inserted central catheters (PICCs) to the entryway of the heart without relying on x-ray or fluoroscopy confirmation of correct catheter placement.